David Parichy is the Pratt-Ivy Foundation Distinguished Professor of Morphogenesis at the University of Virginia, with affiliations in the Department of Biology and Cell Biology. He leads the Parichy Lab, focusing on developmental genetics and evolutionary biology of pigment patterns in Danio fishes. University: University of Virginia Department: Biology and Cell Biology Lab: Parichy Lab His research explores neural crest cell contributions to adult form, emphasizing pigment pattern evolution across genes-to-populations scales. Key systems include zebrafish and relatives, with work on: Stripe/spot formation mechanisms Thyroid hormone regulation of development Stem cell dynamics and regeneration Scale morphogenesis and skeletal phenomics Evolution of novel cell types in clownfish Amphibian developmental biology Lab publications reveal insights into cell-cell interactions, heterochrony, and genetic architectures underlying coloration. Notable awards include the Pratt-Ivy Foundation Distinguished Professorship. His team trains graduate students and postdocs in interdisciplinary approaches combining genetics, imaging, and evolutionary analysis.
Andy J. Minn, M.D., Ph.D. is an Adjunct Professor of Radiation Oncology at the University of Pennsylvania Perelman School of Medicine, an Associate Investigator in the Abramson Family Cancer Research Institute, and Director of the Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation. He also serves as an Attending Physician in Radiation Oncology at the Hospital of the University of Pennsylvania and the Philadelphia VA Medical Center, and holds memberships in the Abramson Cancer Center, the Institute for Immunology, and the Parker Institute for Cancer Immunotherapy. Education: BA (Biology), University of Chicago, 1992 Ph.D. (Immunology), University of Chicago, 1999 M.D. (Medicine), University of Chicago, 2000 Research Interests: Dr. Minn’s laboratory investigates how interferon-stimulated gene programs—normally deployed against viral pathogens—are activated by endogenous “virus-mimicking” signals within tumors. His group studies: The identity of tumor-derived nucleic acids and exosomal RNAs that trigger pattern recognition receptors (PRRs) and anti-viral interferon signaling. The evolutionary pressures that lead cancer cells to co-opt these pathways. How chronic interferon signaling can either enhance or suppress anti-tumor immunity depending on context, thereby influencing responses to radiation, chemotherapy, and immune checkpoint blockade. Translational strategies to combine JAK/STAT inhibition, CAR-T engineering, and radiation to overcome immunotherapy resistance. Recent Publication Trends: Over the past decade, the Minn laboratory has produced a steady stream of high-impact papers that illuminate the dual roles of interferon signaling in cancer. Their 2024 Science study provided clinical evidence that JAK inhibition plus PD-1 blockade can overcome adaptive resistance in non-small cell lung cancer. Earlier work, including 2019 and 2016 Cell papers, dissected opposing interferon functions that coordinate innate and adaptive immunity during checkpoint blockade. Additional studies have linked micronuclei formation, exosome-mediated RNA transfer, and epigenetic memory to therapy resistance, establishing a cohesive narrative that spans basic discovery, mechanistic dissection, and early-phase clinical translation. Scientific Awards & Honors: No specific named awards are listed in the provided text; however, his continuous funding from the Mark Foundation, leadership of a major center, and frequent publication in top-tier journals attest to significant peer recognition. Advising & Team Science: Dr. Minn mentors a diverse team: Graduate students: Lex Johnson (Immunology), Bihui Xu (Cancer Biology), Erica Dhuey (Cancer Biology), Lisa Cucolo (Cell Biology), Jingya Qiu (Genomics and Computational Biology), Darwin Ye (Cancer Biology), Yuwei Qi (Cell Biology), Shangshang Wang (Chemistry). Post-doctoral fellows: Yuanming Xu, Fevzi Demircioglu, Xiang Ni. Research staff: Caitlin Foley (Research Fellow), Yongjun Yu (Senior Lab Manager). Rotation projects are continually available, and the lab actively engages in cross-disciplinary collaborations—most notably with Carl June’s group for CAR-T cell engineering—through the Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation.
Prof. Dr. Ömer Faruk Bayrak is a leading academic at Yeditepe University , holding the position of Professor within the Faculty of Medicine, Department of Medical Genetics . His work bridges genetics, molecular biology, and stem cell research with a focus on cancer pathogenesis , particularly chordoma and glioblastoma . PhD in Medical Genetics (2010, Selçuk University) Master's in Medical Genetics (2006, Atatürk University) BSc in Biology (2002, Atatürk University) Bayrak's research centers on microRNA regulation, epigenetic mechanisms , and genomic instability in cancers . His recent work explores: Mitochondrial DNA dynamics in glioblastoma angiogenesis Role of transcription factors in tumor progression Nanoparticle-based gene silencing strategies Calorie restriction's impact on aging and cancer He has pioneered studies on chordoma cancer stem cells and DNA methylation patterns in neurodegenerative diseases. Recipient of Best Oral Presentation award (Turkish Society of Medical Genetics) Supervised numerous PhD/MSc theses on cancer genetics Keynote speaker at international cancer research congresses
George Coupland is a Professor and Director at the Max Planck Institute for Plant Breeding Research , leading the Department of Plant Developmental Biology . His research focuses on the genetic and molecular mechanisms underlying plant reproductive development and perennial life history evolution, primarily in Arabidopsis thaliana and Arabis alpina . Key areas include floral induction networks , environmental signaling integration , and perennial adaptation genomics . 2025 : FD/FDP bZIP interactions in florigen signaling 2024 : Meristem shape-identity coupling 2023 : Urban adaptation in A. thaliana His work combines genetic mapping , confocal imaging , and CRISPR-based functional analysis to dissect regulatory pathways. Articles highlight miRNA dynamics , transcription factor networks , and dormancy-flowering tradeoffs . Collaborations span Andrea Fulgione (population genetics) and Pau Formosa-Jordan (multicellular modeling). Scientific contributions include 2025: FRS (Fellow of the Royal Society) 2021: PLoS Biology publication on miR172 family ResearchGate profiles show over 384 publications and 103,041 reads , emphasizing his leadership in plant developmental biology . The A. alpina model system development enables comparative studies of annual-perennial divergence .
Lorenzo Piemonti serves as Associate Professor of Endocrinology at Vita Salute San Raffaele University in Milan, Italy, and holds key leadership positions at the San Raffaele Scientific Institute where he directs the Diabetes Research Institute and the Department of Regenerative Medicine and Transplantation. He previously served as Visiting Professor at Vrije Universiteit Brussels (2016-2022) and will serve as President of the International Pancreas and Islet Transplantation Association (IPITA) for 2025-2027. His research focuses on diabetes pathophysiology, beta cell biology, and regenerative medicine approaches to diabetes treatment. Key areas include beta cell replacement therapies, immune tolerance induction strategies, stem cell differentiation for insulin-producing cells, and the development of biomaterials to support islet transplantation. He has pioneered work in dendritic cell biology related to diabetes autoimmunity and has significant contributions to pancreatic oncology research. Dr. Piemonti's recent publications demonstrate a strong focus on translational research bridging basic science discoveries with clinical applications, particularly in islet transplantation outcomes, stem cell-derived beta cells, immune tolerance strategies, and precision medicine approaches to diabetes classification and treatment. Premio Alcmeone (2012) from Società Italiana di Diabetologia Premio per Giovani Ricercatori (2005) from Fondazione Guido Berlucchi As a physician-scientist, Dr. Piemonti maintains active editorial roles as Section Editor for Cell Transplantation and Associate Editor for Transplant International and Journal of Endocrinological Investigation. His leadership extends to multiple international committees including the European Pancreas and Islet Transplant Registry steering committee and various roles within IPITA. He coordinates the European Consortium for Islet Transplantation, which has provided human beta cell products for research and clinical applications across Europe since 2000. His laboratory maintains active collaborations across multiple European institutions through the European Consortium for Islet Transplantation and participates in numerous clinical trials related to beta cell replacement therapies and immune interventions for diabetes.
Brian Cleary serves as an Assistant Professor in Boston University's Faculty of Computing & Data Sciences (CDS), with cross-appointments in Biology and Biomedical Engineering departments. He is a core faculty member in the Bioinformatics Program and the Biological Design Center at the Rajen Kilachand Center for Integrated Life Sciences & Engineering, conducting interdisciplinary research at the intersection of computer science and biology. His educational trajectory includes dual undergraduate degrees in Biology and Business, Economics, and Management from Caltech, followed by 8 years developing trading algorithms in finance before returning to academia. He completed his PhD in Computational and Systems Biology at MIT in 2019. Cleary's research pioneers computational approaches to decipher spatial gene expression patterns in tissues, focusing on theoretical frameworks that transform cellular and tissue physiology understanding. His lab implements paired computational-experimental methodologies to study organ development (particularly brain and ovary), disease progression mechanisms, and tissue organization principles through machine learning and statistical innovations. Analysis of his recent publications reveals dominant themes in compressed sensing techniques for high-throughput biological interrogation, spatial transcriptomics optimization, and scalable genetic screening methods. His work consistently bridges algorithmic innovation with biological discovery across reproductive biology, cardiovascular disease, and infectious disease diagnostics. Scientific recognition includes: Independent Broad Fellow at the Broad Institute of MIT and Harvard Cleary actively recruits PhD students and postdocs for his Algorithmic Lens on Biology Laboratory, leveraging both computational and wet-lab approaches. His research program emphasizes experimental design informed by statistical learning theory to overcome scalability limitations in biological measurement systems. The Algorithmic Lens on Biology Laboratory operates across two physical locations: the Center for Computing and Data Sciences (15th floor) and the Biological Design Center (6th floor in CILSE), employing random composite experiments and low-dimensional feature learning to study cellular pathways and tissue organization at unprecedented scales.
Vitaly Citovsky is a SUNY Distinguished Professor in the Department of Biochemistry and Cell Biology at Stony Brook University. His research focuses on fundamental mechanisms of plant-pathogen interactions with significant implications for plant biotechnology and genetic engineering. His primary research interests include: Genetic transformation of plant cells by Agrobacterium Intercellular transport of plant viruses and plant cell proteins Remodeling of plant chromatin by histone modifications Analysis of Citovsky's recent publications reveals a sustained focus on molecular mechanisms of plant-pathogen interactions. His work demonstrates how Agrobacterium manipulates plant cellular machinery for genetic transformation, explores viral movement through plasmodesmata, and investigates epigenetic regulation of plant genes. The research spans molecular, cellular, and organismal levels, with applications in plant biotechnology and understanding fundamental biological processes across kingdoms. Scientific achievements include: SUNY Distinguished Professor title U.S. patent # 5,831,020: Protein-Mediated Nuclear Import of DNA U.S. patent # 6,902,886: Genetic Assay for Protein Nuclear Transport U.S. patent # 7,659,447: Increasing Host Plant Susceptibility to Agrobacterium Infection by Overexpression of the Arabidopsis VIP1 Gene Citovsky actively mentors several postdoctoral researchers and has trained numerous scientists throughout his career. His laboratory has received continuous funding from major agencies including the National Science Foundation (NSF), National Institutes of Health (NIH), and the U.S. Department of Agriculture (USDA), supporting innovative research at the intersection of plant pathology, molecular biology, and biotechnology. His research group operates a sophisticated molecular biology laboratory focused on protein-protein interactions, gene expression analysis, and plant genetic transformation techniques, with findings regularly featured on the covers of prestigious journals including Plant Physiology and Molecular Plant Pathology.
Dr. Lorna Young is a Lecturer in the Department of Molecular and Clinical Cancer Medicine (MCCM) at the University of Liverpool . With a background in Microbiology and Immunology, she transitioned to Cancer Biology through her PhD work on pathogenic E. coli mechanisms at Newcastle University, followed by postdoctoral studies on cytoskeletal dynamics in the Higgs Lab (Dartmouth) and Zech Lab (University of Liverpool). Research Focus : Her work explores the interplay between cytoskeletal networks, cell migration, and cancer metastasis. Key areas include nuclear force coupling in invasive migration, filopodial assembly mediated by formin proteins, focal adhesion dynamics, and mechanical signaling in cancer progression. She bridges microbiology/immunology with mechanobiology in oncology. Publication Trends : Her 2015-2023 articles focus on cytoskeletal regulators (formins, Ena/VASP) in cell migration and adhesion. Recent work (2023) examines 3D matrix adhesion feedback in metastatic migration, while 2018 studies address filopodia assembly and focal adhesion splitting. All publications integrate molecular and cellular biology approaches. Teaching & Leadership : Since 2022, she contributes to Biomedical Sciences undergraduate programs and now coordinates modules across UG and MSc programs (LIFE323, BIOS102) at University of Liverpool. She also serves as an Education Lead , demonstrating commitment to pedagogy and student engagement.
Kathryn Luker is a Researcher in the Department of Radiology at the University of Michigan Medical School, affiliated with the Biointerfaces Institute. She specializes in molecular imaging of cell signaling in cancer, developing fluorescence and bioluminescence tools for single-cell analysis of tumor microenvironments. BS in Chemistry (University of Kansas, 1987) PhD in Biochemistry & Molecular Biology (Washington University, 1993) Research Interests: Biochemical mechanisms of chemokine/growth factor signaling in cancer progression, autocrine/paracrine signaling, fluorescence/bioluminescence reporters, custom image analysis, and multiscale computational modeling of tumor environments. Her recent work focuses on CXCR4 inhibition in breast cancer immunotherapy, CX43 -mediated tumor-stroma interactions in bone marrow metastases, and machine learning approaches to decode cancer cell heterogeneity. She has received major grants from NIH, Army-DoD, and the W. M. Keck Foundation. Mentoring: Committed to team-based mentorship, she has co-mentored over 70 trainees across biology, medicine, engineering, and computational disciplines.
Professor Stefano Pluchino is a faculty member at the University of Cambridge , affiliated with the School of Clinical Medicine and Department of Clinical Neurosciences . His research focuses on regenerative neuroimmunology , particularly the role of stem cells and metabolic pathways in treating neuroinflammatory and neurodegenerative diseases like Multiple Sclerosis (MS) . He leads clinical trials, including the first-in-kind use of allogeneic neural stem cells in progressive MS patients. Research Interests : Neuroimmunology, stem cell biology, neuroinflammation, metabolic therapies, and regenerative medicine in MS and other neurodegenerative disorders. Article Trends : Recent work highlights mitochondrial metabolism , extracellular vesicles , and metabolic fuels in modulating neuroinflammation and promoting brain repair. Labs & Teams : His lab employs CRISPR gene editing , human organoid models , single-cell RNAseq , and imaging mass spectrometry to study smoldering neuroinflammation and develop precision therapies.
Jan Wilhelm Kornfeld is a Professor at the Department of Biochemistry and Molecular Biology, University of Southern Denmark, leading a research group focused on epigenetic regulation of energy metabolism in cardiometabolic diseases. After obtaining his PhD in Cell Biology from the Boltzmann Institute for Cancer Research (2008), he conducted postdoctoral research with Jens Brüning in Germany (2013), where he pioneered studies on obesity-associated microRNAs and hepatic insulin resistance. His independent research at CECAD (2013) and Max Planck Institute for Metabolism Research (2014) has been supported by prestigious grants including the Emmy-Noether Grant (2014) and ERC Starting Grant (2015). Education: PhD in Cell Biology, Boltzmann Institute for Cancer Research, Austria (2008) Postdoctoral Training, Jens Brüning Lab, Germany (2013) The Kornfeld Lab investigates epigenetic regulatory processes such as non-coding microRNAs (miRNA) and chromatin modifications that impact organismal, tissue, and cellular energy balance. Their research integrates molecular genomics , transgenic animal models , and inter-organ crosstalk to uncover disease-associated molecular signatures in obesity and type 2 diabetes (T2D). Key projects include miRNA perturbation in vivo, nutritional intervention strategies, and development of adeno-associated virus (AAV) gene therapy tools . Recent publications highlight work on dietary sulfur amino acid restriction , mitochondrial dysfunction in brown adipocytes, and miR-let-7 in intergenerational metabolic decline. His research spans transcriptional regulation , metabolomics , and non-coding RNA mechanisms in metabolic diseases. Scientific Awards: Emmy-Noether Grant (2014) ERC Starting Grant (2015) The lab actively trains Bachelor, Master, and ISA students in hypothesis-driven research, focusing on RNA-mediated gene regulation , chromatin dynamics , and (patho)physiological analysis . Collaborations with global experts and industrial partners enhance translational impact.
Aslak Tveito is a Professor and Simula Fellow at Simula Research Laboratory, working within the Department of Computational Physiology. His research spans computational physiology, biophysics, and scientific computing with a strong focus on cardiac electrophysiology and mathematical modeling. Dr. Tveito's research interests center on computational physiology, particularly in the domain of cardiac electrophysiology. His work integrates mathematical modeling, numerical analysis, and computational techniques to understand cardiac function at multiple scales - from cellular to tissue level. He has made significant contributions to developing computational frameworks for modeling excitable tissues, with particular emphasis on the heart. His research bridges the gap between theoretical mathematics and practical physiological applications, creating models that can predict cardiac behavior under normal and pathological conditions. The publication record reveals a strong trend toward increasingly detailed cellular-level modeling of cardiac electrophysiology. Recent work focuses on nano-scale phenomena, stem cell-derived cardiomyocyte modeling, and the development of efficient computational frameworks that maintain physiological accuracy. His research demonstrates a consistent trajectory from macroscopic cardiac models toward cellular and subcellular resolution, with growing integration of experimental data from microphysiological systems. There's also a clear emphasis on practical applications, particularly in drug testing and arrhythmia mechanisms. Dr. Tveito has established himself as a leading researcher in computational cardiac electrophysiology through his extensive publication record spanning multiple decades. His work has been published in high-impact journals across computational biology, physiology, and applied mathematics. His research program demonstrates strong continuity in mathematical modeling of cardiac systems, with evolving focus toward higher-resolution cellular models and integration with experimental cardiac microphysiological systems. The collaborative nature of his work is evident through numerous co-authorships with both computational scientists and experimental biologists.
Vilde Olsson Lalun is a postdoctoral fellow at the Centre for Ecological and Evolutionary Synthesis (CEES), University of Oslo. She obtained her BSc and MSc in Molecular Biology at UiO in 2013 and 2015, respectively, and completed her PhD in Genetics in 2020 under the supervision of Prof. Melinka Alonso Butenko. Her current research integrates experimental biology and bioinformatics within the interdisciplinary REPEAT project, focusing on how short tandem repeat (STR) variation influences adaptation and gene expression in Arabidopsis thaliana and Atlantic cod. Education 2013 – BSc in Molecular Biology, University of Oslo 2015 – MSc in Molecular Biology (Plant Genetics), University of Oslo 2020 – PhD in Genetics, Department of Biosciences, University of Oslo Thesis: "Molecular investigation of receptor kinase signaling specificity in Arabidopsis thaliana" Research Interests Dr Lalun’s work sits at the intersection of molecular plant biology , evolutionary genomics , and functional genetics . During her PhD she dissected peptide ligand–receptor kinase specificity using the IDA–HAE/HSL2 signalling module as a model. Presently, she investigates how STR length polymorphisms modulate gene expression and organismal fitness under environmental stress, leveraging both Arabidopsis and Atlantic cod as complementary model systems. Core methodological strengths include generation of transgenic lines, advanced live-cell imaging, quantitative microscopy, and integrative bioinformatic analyses. She actively contributes to the REPEAT consortium, an interdisciplinary team that addresses fundamental questions of genome plasticity and climate adaptation. By coupling large-scale comparative genomics with targeted experiments, the project aims to clarify how repetitive DNA elements shape regulatory networks controlling development and immunity. Publication Profile Across 11 peer-reviewed papers (2017-2025) in high-impact journals such as Nature Communications , PNAS , eLife , and Plant Cell , her research spans three major themes: Functional dissection of peptide signalling pathways in plant development and immunity. Comparative genomics of short tandem repeats and their impact on gene regulation. Mechanistic studies of receptor kinase activation and signalling specificity. The 2024-2025 outputs include a lead-author review on plant peptide ligands and multi-omics studies that link STR variation to gene body architecture in eukaryotes. Teaching & Outreach Dr Lalun is a committed educator and science communicator. She instructs two undergraduate courses: BIOS1120 – Physiology BIOS3610 – Molecular Plant Science Beyond the classroom she co-hosts the Norwegian-language podcast BioPodden , produces popular-science YouTube lectures, and gives interviews that demystify plant genetics for the public. Collaborations & Networks She is an active member of the Butenko Group at UiO and collaborates extensively within the CEES and the national REPEAT project network. The lab provides cutting-edge facilities for molecular biology, microscopy and bioinformatics, ensuring a vibrant environment for integrative research.
Dr. Rajiv Dhir is Professor of Pathology at the University of Pittsburgh and holds multiple leadership roles at UPMC, including Executive Vice Chairman of Anatomic Pathology, Chief of Pathology at UPMC Shadyside, Director of the Genitourinary Pathology Center of Excellence, and Medical Director of the Pitt Biospecimen Core. He oversees tissue banking operations supporting translational research across UPMC hospitals and international consortia. Education: MBBS, New Delhi, India (1983) MBA, University of Pittsburgh (2012) Research Focus: Dr. Dhir investigates molecular alterations in genitourinary cancers (prostate, bladder, renal) using multi-omics approaches. His work bridges biomarker discovery, AI-enhanced diagnostics, and clinical validation, with emphasis on proteomic perturbations and therapeutic target identification. Recent Publications: His 180+ publications demonstrate leadership in cancer genomics (TCGA), artificial intelligence applications in pathology, and biobanking science, reflecting cross-disciplinary collaboration and clinical translation. Grants & Infrastructure: As PI for CPTAC and CHTN initiatives, he secures NIH/NCI funding for large-scale projects. He directs the Pitt Biospecimen Core—a critical resource for tissue-based research—and developed institutional honest broker systems for data integration.
Prof. Oren Schuldiner is a Professor and incumbent of the Prof. Erwin Netter Professorial Chair of Cell Biology at the Weizmann Institute of Science, holding dual appointments in the Department of Molecular Cell Biology and Department of Molecular Neuroscience. His research focuses on understanding the molecular mechanisms that govern neural circuit wiring and remodeling during development using the powerful genetic model system of Drosophila melanogaster. Prof. Schuldiner's research primarily investigates neuronal remodeling, with specific emphasis on axon pruning and regrowth in the Drosophila mushroom body. His lab explores how intracellular signaling, trafficking, cytoskeletal changes, and transcriptional regulation contribute to these processes. The research has significant implications for understanding neurodevelopmental disorders including autism, schizophrenia, and Alzheimer's disease, as well as providing insights into axon regeneration following injury. Analysis of Prof. Schuldiner's publication record shows a consistent focus on developmental neurobiology using Drosophila models. His research spans molecular mechanisms of axon pruning, glia-neuron interactions, transcriptional regulation of remodeling, and the development of innovative techniques like tissue-specific CRISPR screening and ex vivo brain culturing. The work bridges fundamental developmental biology with potential applications in understanding neural degeneration and regeneration. Prof. Schuldiner's lab has developed several cutting-edge methodologies including tissue-specific CRISPR for in vivo screening, high-resolution RNA-seq approaches, ex vivo brain culturing systems for live imaging, and specialized assays for studying neurite sprouting. These tools have enabled his team to make significant contributions to understanding the genetic and molecular basis of neuronal remodeling, with findings published consistently in top-tier journals across neuroscience, cell biology, and developmental biology fields.
